Commonwealth of Pennsylvania Public School Empls Retrmt SYS Boosts Position in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in Ryan Specialty Holdings, Inc. (NYSE:RYANFree Report) by 4.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 23,498 shares of the company’s stock after buying an additional 948 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Ryan Specialty were worth $1,508,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also added to or reduced their stakes in RYAN. Raymond James Financial Inc. purchased a new stake in shares of Ryan Specialty in the fourth quarter valued at approximately $94,484,000. Principal Financial Group Inc. raised its position in Ryan Specialty by 115.2% during the 4th quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company’s stock valued at $117,619,000 after purchasing an additional 981,505 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in shares of Ryan Specialty by 43.9% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 938,187 shares of the company’s stock worth $62,286,000 after buying an additional 286,380 shares during the period. JPMorgan Chase & Co. grew its position in shares of Ryan Specialty by 107.5% during the 3rd quarter. JPMorgan Chase & Co. now owns 459,464 shares of the company’s stock worth $30,504,000 after buying an additional 238,064 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its stake in shares of Ryan Specialty by 16.8% during the fourth quarter. Bank of New York Mellon Corp now owns 898,865 shares of the company’s stock valued at $57,671,000 after buying an additional 129,354 shares during the period. 84.82% of the stock is currently owned by institutional investors.

Ryan Specialty Stock Performance

RYAN opened at $72.43 on Wednesday. The company has a market cap of $18.97 billion, a P/E ratio of 104.97, a price-to-earnings-growth ratio of 1.19 and a beta of 0.71. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The firm’s 50-day moving average price is $68.39 and its 200-day moving average price is $68.13. Ryan Specialty Holdings, Inc. has a 52-week low of $48.48 and a 52-week high of $75.97.

Ryan Specialty (NYSE:RYANGet Free Report) last issued its quarterly earnings results on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.02). Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The company had revenue of $663.53 million for the quarter, compared to analyst estimates of $658.80 million. As a group, equities analysts anticipate that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th were paid a $0.12 dividend. This is a positive change from Ryan Specialty’s previous quarterly dividend of $0.11. The ex-dividend date was Tuesday, March 4th. This represents a $0.48 dividend on an annualized basis and a yield of 0.66%. Ryan Specialty’s dividend payout ratio (DPR) is 69.57%.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on RYAN. Keefe, Bruyette & Woods lowered their price objective on shares of Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating for the company in a research note on Friday, February 21st. Morgan Stanley initiated coverage on shares of Ryan Specialty in a research report on Thursday, December 5th. They issued an “overweight” rating and a $90.00 price target for the company. Wells Fargo & Company lifted their price objective on shares of Ryan Specialty from $64.00 to $69.00 and gave the company an “equal weight” rating in a report on Friday, February 21st. Royal Bank of Canada reduced their price objective on shares of Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating for the company in a research note on Friday, February 21st. Finally, UBS Group increased their target price on Ryan Specialty from $82.00 to $84.00 and gave the company a “buy” rating in a research report on Wednesday, February 26th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Ryan Specialty presently has a consensus rating of “Hold” and an average price target of $75.27.

Check Out Our Latest Stock Analysis on RYAN

Insiders Place Their Bets

In other news, EVP Brendan Martin Mulshine sold 30,000 shares of the company’s stock in a transaction on Friday, March 14th. The shares were sold at an average price of $69.30, for a total value of $2,079,000.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Nicholas Dominic Cortezi sold 35,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was sold at an average price of $67.15, for a total transaction of $2,350,250.00. Following the transaction, the director now directly owns 25,809 shares of the company’s stock, valued at approximately $1,733,074.35. This trade represents a 57.56 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 241,360 shares of company stock valued at $16,006,428. 11.10% of the stock is owned by company insiders.

About Ryan Specialty

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

See Also

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.